These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36003325)

  • 1. Altered high-energy phosphate and membrane metabolism in Pelizaeus-Merzbacher disease using phosphorus magnetic resonance spectroscopy.
    Laukka JJ; Kain KM; Rathnam AS; Sohi J; Khatib D; Kamholz J; Stanley JA
    Brain Commun; 2022; 4(4):fcac202. PubMed ID: 36003325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered brain high-energy phosphate metabolism in mild Alzheimer's disease: A 3-dimensional
    Rijpma A; van der Graaf M; Meulenbroek O; Olde Rikkert MGM; Heerschap A
    Neuroimage Clin; 2018; 18():254-261. PubMed ID: 29876246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered phospholipid metabolism in schizophrenia: a phosphorus 31 nuclear magnetic resonance spectroscopy study.
    Weber-Fahr W; Englisch S; Esser A; Tunc-Skarka N; Meyer-Lindenberg A; Ende G; Zink M
    Psychiatry Res; 2013 Dec; 214(3):365-73. PubMed ID: 24045051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative proton MRS of Pelizaeus-Merzbacher disease: evidence of dys- and hypomyelination.
    Hanefeld FA; Brockmann K; Pouwels PJ; Wilken B; Frahm J; Dechent P
    Neurology; 2005 Sep; 65(5):701-6. PubMed ID: 16157902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myelin-associated glycoprotein gene mutation causes Pelizaeus-Merzbacher disease-like disorder.
    Lossos A; Elazar N; Lerer I; Schueler-Furman O; Fellig Y; Glick B; Zimmerman BE; Azulay H; Dotan S; Goldberg S; Gomori JM; Ponger P; Newman JP; Marreed H; Steck AJ; Schaeren-Wiemers N; Mor N; Harel M; Geiger T; Eshed-Eisenbach Y; Meiner V; Peles E
    Brain; 2015 Sep; 138(Pt 9):2521-36. PubMed ID: 26179919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-related changes in a patient with Pelizaeus-Merzbacher disease determined by repeated 1H-magnetic resonance spectroscopy.
    Mori T; Mori K; Ito H; Goji A; Miyazaki M; Harada M; Kurosawa K; Kagami S
    J Child Neurol; 2014 Feb; 29(2):283-8. PubMed ID: 24056155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duplication of proteolipid protein gene: a possible major cause of Pelizaeus-Merzbacher disease.
    Wang PJ; Hwu WL; Lee WT; Wang TR; Shen YZ
    Pediatr Neurol; 1997 Sep; 17(2):125-8. PubMed ID: 9367291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pelizaeus-Merzbacher disease: an X-linked neurologic disorder of myelin metabolism with a novel mutation in the gene encoding proteolipid protein.
    Gencic S; Abuelo D; Ambler M; Hudson LD
    Am J Hum Genet; 1989 Sep; 45(3):435-42. PubMed ID: 2773936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic Resonance Imaging and Spectroscopy Analysis in a Pelizaeus-Merzbacher Disease Rat Model.
    Ishikawa M; Sawaya R; Hirayama M; Ueda J; Saito S
    Diagnostics (Basel); 2022 Aug; 12(8):. PubMed ID: 36010215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Energetic and cell membrane metabolic products in patients with primary insomnia: a 31-phosphorus magnetic resonance spectroscopy study at 4 tesla.
    Harper DG; Plante DT; Jensen JE; Ravichandran C; Buxton OM; Benson KL; O'Connor SP; Renshaw PF; Winkelman JW
    Sleep; 2013 Apr; 36(4):493-500. PubMed ID: 23564996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pelizaeus-Merzbacher disease and spastic paraplegia type 2: two faces of myelin loss from mutations in the same gene.
    Hudson LD
    J Child Neurol; 2003 Sep; 18(9):616-24. PubMed ID: 14572140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging and spectroscopic analysis in 5 cases of Pelizaeus-Merzbacher disease: metabolic abnormalities as diagnostic tools.
    Lee E; Yum MS; Choi HW; Yoo HW; You SJ; Lee EH; Ko TS
    Korean J Pediatr; 2012 Oct; 55(10):397-402. PubMed ID: 23133488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral bioenergetic differences measured by phosphorus-31 magnetic resonance spectroscopy between bipolar disorder and healthy subjects living in two different regions suggesting possible effects of altitude.
    Hwang J; DeLisi LE; Öngür D; Riley C; Zuo C; Shi X; Sung YH; Kondo D; Kim TS; Villafuerte R; Smedberg D; Yurgelun-Todd D; Renshaw PF
    Psychiatry Clin Neurosci; 2019 Sep; 73(9):581-589. PubMed ID: 31125152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral metabolism in experimental hydrocephalus: an in vivo 1H and 31P magnetic resonance spectroscopy study.
    Braun KP; van Eijsden P; Vandertop WP; de Graaf RA; Gooskens RH; Tulleken KA; Nicolay K
    J Neurosurg; 1999 Oct; 91(4):660-8. PubMed ID: 10507389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroradiologic correlates of clinical disability and progression in the X-linked leukodystrophy Pelizaeus-Merzbacher disease.
    Laukka JJ; Stanley JA; Garbern JY; Trepanier A; Hobson G; Lafleur T; Gow A; Kamholz J
    J Neurol Sci; 2013 Dec; 335(1-2):75-81. PubMed ID: 24139698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel pathologic findings in patients with Pelizaeus-Merzbacher disease.
    Laukka JJ; Kamholz J; Bessert D; Skoff RP
    Neurosci Lett; 2016 Aug; 627():222-32. PubMed ID: 27222925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton and 31-phosphorus neurospectroscopy in the study of membrane phospholipids and fatty acid intervention in schizophrenia, depression, chronic fatigue syndrome (myalgic encephalomyelitis) and dyslexia.
    Puri BK
    Int Rev Psychiatry; 2006 Apr; 18(2):145-7. PubMed ID: 16777668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two autopsy cases with Pelizaeus-Merzbacher disease phenotype of adult onset, without mutation of proteolipid protein gene.
    Sasaki A; Miyanaga K; Ototsuji M; Iwaki A; Iwaki T; Takahashi S; Nakazato Y
    Acta Neuropathol; 2000 Jan; 99(1):7-13. PubMed ID: 10651021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain N-acetylaspartate is elevated in Pelizaeus-Merzbacher disease with PLP1 duplication.
    Takanashi J; Inoue K; Tomita M; Kurihara A; Morita F; Ikehira H; Tanada S; Yoshitome E; Kohno Y
    Neurology; 2002 Jan; 58(2):237-41. PubMed ID: 11805250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pelizaeus-Merzbacher disease, Pelizaeus-Merzbacher-like disease 1, and related hypomyelinating disorders.
    Hobson GM; Garbern JY
    Semin Neurol; 2012 Feb; 32(1):62-7. PubMed ID: 22422208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.